Xi L, Coello MC, Litle VR, Raja S, Gooding WE, Yousem SA, El-Hefnawy T, Landreneau RJ, Luketich JD, Godfrey TE. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res. 12(8):2484-91, 2006.

Yanowitz TD, Potter DM, Bowen A, Baker RW, Roberts JM., Variability in cerebral oxygen delivery is reduced in premature neonates exposed to chorioamnionitis. Pediatric Research. 59(2):299-304, 2006.

Van Le TS, Miller R, Barder T, Babjuk M, Potter DM, Getzenberg RH., Highly specific urine-based marker of bladder cancer. Urology. 66(6):1256-60, 2005.

Wang J, Xi L, Gooding W, Godfrey TE, Ferris RL. Chemokine receptors 6 and 7 identify a metastatic expression pattern in squamous cell carcinoma of the head and neck. Adv Otorhinolaryngol., 62:121-33, 2005.

Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Ferrone S, DeLeo A, Ferris Rl. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res. 65 (23): 11146-1155, 2005.

Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris FL, Grandis JR. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene.24(55): 8216, 2005.

Singal R, Das PM, Manoharan M, Reis IM, Schlesselman JJ. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. Oncol Rep. 14(2): 569-573, 2005.

Gologan A, Bastacky S, McHale T, Yu J, Cai C, Monzon F, Dhir R. Age-associated changes in Alpha-methyl CoA racemase (AMACR) expression in non-neoplastic prostatic tissues. Am J Surg Pathol. 29(11):1435-41, 2005.

Xi L, Lyons-Weiler, J, Coello MC, Huang X, Gooding WE, Luketich JD, Godfrey TE. Prediction of Lymph Node Metastasis by Analysis of Gene Expression Profiles in Primary Lung Adenocarcinomas. Clin. Cancer Res. 11(11): 4128-4135, 2005.

Kuss I, Schaefer C, Godfrey TE, Ferris RL, Harris JM, Gooding W, Whiteside TL. Recent thymic emigrants and subsets of naïve and memory T cells in the circulation of patients with head and neck cancer. Clin. Immun. 116;27-36, 2005.

Thomas SM, Rugin-Grandis J, Wentzel AL, Gooding WE, Yan Lui VW, Siegfried JM. Gastrin-Releasing Peptide Receptor Mediates Activation of the Epidermal Growth Factor Receptor in Lung Cancer Cells. Neoplasia 7(4):426-431, 2005.

Day RS, Shackney SE, Peters WP. The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer. British Journal of Cancer 92, 47- 54, 2005.

Modugno F, Zmuda JM, Potter D, Cai C, Ziv E, Cummings S, Stone KL, Morin PA, Greene D, Cauley JA. The Association of Estrogen Receptor Alpha Polymorphisms with Breast Cancer Risk in Older White Women. Int. J. Cancer: 116(6), 984-991, 2005.

Modugno F, Zmuda JM, Potter D, Cai C, Ziv E, Cummings S, Stone KL, Morin PA, Greene D, Cauley JA. Estrogen Metabolizing Polymorphisms and Breast Cancer Risk among Older White Women.Breast Cancer Res Treat. 93(3):261-70, 2005.

Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, Seliger B. Defects in the Human Leukocyte Antigen Class I Antigen-Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome. Clin Cancer Res 11 (7), 2005.

Ferris RL, Xi L, Raja S, Hunt JL, Wang J, Gooding WE, Kelly L, Chang J, Luketich JD, Godrey TE. Molecular Staging of Cervical Lymph Nodes in Squamous Cell Carcinoma of the Head and Neck. Cancer Res. 65(6): 2147-2156, 2005.

Herrera LJ, El-Hefnawy T, Queriroz de Oliveira PE, Raja S, Finkelstein S, Gooding W, Luketich JD, Godfrey TE, Hughes SJ. The HGF Receptor c-Met is Overexpressed in Esophageal Adenocarcinoma. Neoplasia 7(1):75-84, 2005.

Xi L, Luketich JD, Raja S, Gooding WE, Litle VR, Coello MC, Finkelstein SD, Chestney ML, Landreneau RJ, Hughes SJ, Godfrey TE. Molecular staging of Lymph Nodes from Patients with Esophageal Adenocarcinoma. Clin Cancer Res 11, 1099-1109, 2005.

Potter DM. A permutation test for inference in logistic regression with small- and moderate-sized datasets. Statistics in Medicine, 24:693-708, 2005.

Hershberger PA, Vasquez AC, Kanterewicz B, Land SR, and Nichols M, Regulation of Endogenous Gene Expression in Human Non-Small Cell Lung Cancer Cells by Estrogen Receptor Ligands and Epidermal Growth Factor. Cancer Research, Feb 15;65(4):1598-605, 2005.

Luketich JD, Land SR, Sullivan EA, Alvelo-Rivera M, Ward J, Buenaventura P, Landreneau R, Hart L, Fernando HC, Thoracic epidural versus intercostal nerve catheter plus PCA morphine: a randomized study, Ann Thorac Surg. Jun;79(6):1845-9, 2005.

Ramanathan RK, Ramalingam S, Egorin MJ, Belani CP, Potter DM, Fakih M, Jung LL, Strychor S, Jacobs SA, Friedland DM, Shin DM, Chatta GS, Tutchko S, Zamboni WC. Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies. Cancer Chemotherapy and Pharmacology. 55(4):354-60, 2005.

Oliver CL, Shangary S, Miranda MB, Wang S, Land SR and Johnson DE, Gossypol acts directly on the mitochondria to overcome Bcl-2 and Bcl-XL mediated apoptosis resistance. Mol. Cancer Ther. 4(1): 23-31, 2005.

Muindi JR, Potter DM, Peng Y, Johnson CS, Trump DL. Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation. Cancer Chemotherapy and Pharmacology, 56(5):492-6, 2005.

Herrera LJ, Raja S, Gooding WE, El-Hefnawy T, Kelly L, Luketich JD, Godfrey TE. Quantitative Analysis of Circulating Plasma DNA as a Tumor Marker in Thoracic Malignancies. Clin Chem. 2004 (Epub ahead of print)

Yu J, Dhir D, Gologan A, McHale T, Monzon F, Cai C, Bastacky S. Methylacyl CoA Racemase (AMACR) Immunoreactivity in
Non-Neoplastic Prostatic Acinar Epithelium in pts with Reactive vs Neoplastic Prostate Tissue. United States and Canadian Academy of Pathology, March 2004.

Grant MR, Bastacky S, Cai C, Dhir R. Expression of p27kip1 in Prostate Cancer: Correlation with Histopathological Parameters and Clinical Stage. United States and Canadian Academy of Pathology, March 2004.

Gologan A, Bastacky S, McHale T, Yu J, Cai C, Monzon F, Dhir R. Alpha-Methyl CoA Racemase (AMACR) Immunoreactivity in Organ Donor Prostates. United States and Canadian Academy of Pathology, March 2004.

Bakdash S, Bastacky S. Acquafondata M, Notaro M, Gologan A, Cai C, McHale T, Dhir R. Expression of Polymeric Immunoglobulin Receptor (PIGR) in Neoplastic and Non-Neoplastic Prostate Tissue. United States and Canadian Academy of Pathology, March 2004.

Boyer J, Zitelli J, Brodland D, D'Angelo G. Commentary on: Merkel cell carcinoma and the controversial role of adjuvant radiation therapy: clinical choices in the absence of statistical evidence. Journal of the American Academy of Dermatology, 50(3): 437-38, 2004.

Nelson H, Sargent D, Wieand HS, Fleshman J, Anvari M, Stryker S, Beart R, Hellinger M, Richard Flanagan R, Peters W, Ota D. A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer. NEJM 350:2050-2059, 2004.

Smith RE, Colangelo L, Wieand HS, Begovic M, Wolmark N. Adjuvant therapy in carcinoma of the colon: 10-year results of NSABP Protocol C-01. J Natl Cancer Inst 96: 1128-1132, 2004.

Zhou GC, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cycloosygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Clinical Cancer Research 10: 5930-5939, 2004.

Day RS, Shackney SE, Peters WP. The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer. British Journal of Cancer (in press).

Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R. T Stage and Patterns of Sentinel Lymph Node Tumor Metastases as Predictor of Axillary Lymph Node Tumor Burden, Breast Journal 10(2): 101-105, 2004.

Dhir R, Vietmeier B, Arlotti J, Acquafondata M, Landsittel D, Masterson R, Getzenberg RH. Early Identification of Individuals with Prostate Cancer in Negative Biopsies, Journal of Urology 171: 1419-1423, 2004.

Jung LL, Ramanathan RK, Egorin MJ, Jin R, Belani CP, Potter DM, Strychor S, Trump DL, Walko C, Fakih M, Zamboni WC. Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors. Cancer Chemotherapy and Pharmacology, 54(6):487-96, 2004.

Zamboni WC, Jung LL, Egorin MJ, Potter DM, Friedland DM, Belani CP, Agarwala SS, Wong MM, Fakih M, Trump DL, Jin R, Strychor S, Vozniak M, Troetschel M, Ramanathan RK. Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors. Clinical Cancer Research. 10(15):5058-64, 2004.

Li S, Xu J, Makarenkova VP, Tjandrawan T, Vakkila J, Reichert T, Gooding W, Lagenaur CF, Achim CL, Chambers WH, Herberman RB, Whiteside TL, Vujanovic NL. A novel epitope of N-CAM defines precursors of human adherent NK cells. J. Leukoc. Biol, 76, 2004.

Zhang Q, Thomas SM, Xi S, Smithgall TE, Siegfried JM, Kamens J, Gooding WE, Rubin-Grandis J. Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells. Cancer Res. 64, 6166-613, 2004.

Zhang X, Hunt JL, Landsittel DP, Adler-Storthz K, Ferris RL, Shin DM, Zhuo C. Correlation of Protease-activated Receptor-1 (PAR-1) with Differentiation Markers in Squamous Cell Carcinoma of the Head and Neck and Its Implication in Lymph Node Metastasis. Clinical Cancer Research 10:8451-8459, 2004.

Klepchick PR, Dabbs DJ, Bonaventura M, Falk J, Keenan D,Landsittel D, Johnson R. Selective intraoperative consultation for the evaluation of sentinel lymph nodes in breast cancer. American Journal of Surgery. 88(4):429-32, 2004.

Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Rubin-Grandis, J. Mutation of P53 in Head and Neck Squamous Cell Carcinoma Correlates with BCL-2 Expression and Increased Susceptibility to Cisplatin-Induced Apoptosis. Head & Neck, 26(10), 861-869, 2004.

Duvvuri U, Simental AA Jr, D'Angelo G, Johnson JT, Ferris RL, Gooding W, Myers EN. Elective Neck Dissection and Survival in Patients with Squamous Cell Carcinoma of the Oral Cavity and Oropharynx. Laryngoscope 114 (12): 2228-2234, 2004.

Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, Deleo A, Ferris RL. Effect of Human Papillomavirus-16 Infection on CD8+ T-Cell Recognition of a Wild-Type Sequence p53264-272 Peptide in Patients with Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res. 10, 6929-6937, 2004.

Xi S, Gooding WE, Rubin-Grandis J. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene 1-10, 2004.

Habel LA, Dignam JJ, Land SR, Salane M, Capra A, Julian T, Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst. 96: 1467-1472, 2004.

Okada H, Tsugawa T, Sato H, Kuwashima N, Gambotto A, Okada K, Dusak JE, Fellows-Mayle WK, Papworth GD, Watkins SC, Chambers WH, Potter DM, Storkus WJ, Pollack IF. Delivery of Interferon- α Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines. Cancer Res. 64, 5830-5838, 2004.

Singal R, Ferdinand L, Reis IM, Schlesselman JJ. Methylation of multiple genes in prostate cancer and relationship with clinicopathological features of disease. Oncol Rep. (3):631-7, 2004.

Singal R, Ferdinand L, Das PM, Reis IM, Schlesselman JJ. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int J Oncol. (25) 1465-71, 2004.

Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with hormonal contraception. Am J Obstet Gynecol;190:S5-22, 2004.

Raez LE, Cassileth PA, Schlesselman JJ, Sridhar K, Padmanabhan S, Fisher EZ, Baldie PA, Podack ER. Allogeneic vaccination with a B7.1 (CD80) and HLA A gene modified adenocarcinoma cell line in patients with advanced non small cell lung cancer (NSCLC). J Clin Oncol; 22: 2800-7, 2004.

Rubin-Grandis J, Gooding WE, Zamboni BA, Wagener MM, Drenning SD. Miller L, Doyle KJ, Mackinnon SE, Wagner RL. The Gender Gap in Surgical Subspecialty: Analysis of Career and Lifestyle Factors. Arch Otolaryngol Head Neck Surg., 130, 695-702, 2004.

Jing L, Liu L, Yu YP, Dhir R, Acquafondada M, Landsittel D, Cipley C, Stoltz D, Lin F, Michalopoulos G, Wells A, Luo JH, Expression of Myopodin Induces Suppression of Tumor Growth And Metastasis, American Journal of Pathology. Am. J. Pathol. 164(5):1799-806, 2004.

Shackney SE, Smith CA, Pollice A, Brown K, Day R, Julian T, Silverman JF. "Intracellular Patterns of Her-2/neu, ras, and Ploidy Abnormalities in Primary Human Breast Cancers Predict Postoperative Clinical Disease Free Survival". Clinical Cancer Research. May 1;10(9):3042-52. 2004.

Ramanathan RK, Hwang JJ, Zamboni WC, Sinicrope FA, Safran H, Wong MK, Earle M, Brufsky A, Evans T, Troetschel M, Walko C, Day R, Chen HX, Finkelstein S. The low over-expression of HER-2/neu in Advanced Colo-Rectal Cancer limits the usefulness of Trastuzumab (Herceptin®) and Irinotecan as therapy. A Phase II trial. Cancer Invest. 22(6):858-65, 2004.

Day RS, Manning BK, Garrott D, Brufsky AM, Baar J, Egorin MJ, Shirey WE, Friedman C. Evaluation of the OncoTCap (Oncology Thinking Cap) Simulation in Teaching Medical Students about Clinical Trials: Some Successes and Some Surprises. J Cancer Ed. 19(3), 2004.

Ramanathan RK, Lee K, Mckolanis J, Hitbold E, Schraut W, Moser AJ, Warnick E, Whiteside T, Osborn J, Kim H, Day RS, Troetchel M, Finn OJ. Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer. Cancer Immunology and Immunotherapy. 54(3):254-264, 2004.

Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Decreased Absolute Counts of T Lymphocyte Subsets and Their Relation to Disease in Squamous Cell Carcinoma of the Head and Neck. Clin. Cancer Res., 10, 3755-3762, 2004.

Yu Y, Landsittel D, Jing L, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Chandra U, Gilbertson J, Finkelstein S, Michalopoulos G, Becich M, Luo J. Gene Expression Alterations in Prostate Gland Preceding the Development of Prostate Cancer. Journal of J Clin Oncol. Jul 15;22(14):2790-9 2004.

Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project, Twelve year observations concerning lobular carcinoma in situ. Cancer 100(2): 238-244, 2004.

Land SR, Kopec JA, Yothers G, Anderson S, Day R, Tang G, Ganz PA, Fisher B, Wolmark N, Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC versus CMF Chemotherapy: Findings from the National Adjuvant Breast and Bowel Project B-23. Breast Cancer Research, 86: 153-164, 2004.

Siegfried JM, Luketich JD, Stabile LP, Christie N, Gubish CT, Davis AG, and Land SR. Elevated hepatocyte growth factor level correlates with poor outcome in early and late-stage adenocarcinoma of the lung. Chest, May;125(5 Suppl):116S-9S, 2004.

Wang J, Xi L, Hunt JL, Gooding W, Whiteside TL, Chen Z, Godfrey TE, Ferris RL. Expression Pattern of Chemokine Receptor 6 (CCR6) and CCR7 in Squamous Cell Carcinoma of the Head and Neck Identifies a Novel Metastatic Phenotype. Cancer Research, 64, 1861-1866, 2004.

Chung SY, Stein RJ, Landsittel D, Davies BJ, Cuellar DC, Tarin T, Averch TD. Fifteen-year experience with management of extrinsic ureteral obstruction with indwelling unreteral stents. J Urol. Aug;172(2):592-5, 2004.

Ramalingam S, Belani CP, Day RS, Zamboni, BA, Jacobs SA, Jett JR. "Phase II Study of Topotecan and Paclitaxel for Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer". Annals of Oncology. Feb;15(2):247-51. 2004.

Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Zuhowski EG, Pluim D, Hamburger DR, Working PK, Colbern G, Tonda ME, Potter DM, Eiseman JL. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma. Cancer Chemotherapy and Pharmacology, 53(4):329-36, 2004.

Lin Y, Reynolds P, and Feingold F. An Empirical Bayesian Method for Differential Expression Studies Using One-Channel Microarray Data, Statistical Applications in Genetics and Molecular Biology: Vol. 2: No. 1, Article 8, 2003.

Wieand HS. Is Relative risk reduction a useful measure for patients or families who must choose a method of treatment: J. Clin. Oncol. 1:21(23):4263-4, 2003. (Editorial)

Richards TJ, Day RS, Kaminski N. Weakest Link Models for Detecting Small Groups of Genes to Predict Lung Cancer Survival, CAMDA’03 (Critical Assessment of Microarray Data Analysis), Durham, North Carolina, November 2003.

Welsh C, Day R, McGurk C, Masters JRW, Wood RD, Köberle B. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int. J Cancer. Jun 20;110(3):352-61. 2004.

Bryant J, Land S, Allred C, Paik S, Dignam J, Habel L, Smith R, Geyer C, Fisher E, Fisher B, Wolmark N. DCIS: evidence from randomized trials. Breast. Suppl 1:S9, 2003.

Julian TB, Land SR, Wolmark N, NSABP B-35: A clinical trial comparing Anastrozole with tamoxifen in post menopausal patients with ductal carcinoma in situ (DCIS) undergoing lumpectomy with radiation therapy. Breast Diseases, Vol 14, No 2, 121-122, 2003.

Dignam J, Habel L, Land S, Julian T, Fisher B, Wolmark N. Mammographic density and obesity as risk factors for invasive breast cancer following ductal carcinoma in situ (DCIS). Breast. Suppl 1:S18, 2003.

Fisher E, Colangelo L, Wieand S, Fisher B, Wolmark N. Lack of Influence of Cytokeratin-Positive Nimi Micrometastases in negative node Patients with Colorectal Cancer: Findings from the NSABP Protocols R-01 and C-01. Diseases of the Colon and Rectum: 46: 1021-1026, 2003.

Dhir R, Vietmeier B, Arlotti J, Acquafondata M, Landsittel D, Masterson R, Getzenberg RH. Early Identification of Individuals with Prostate Cancer in Negative Biopsies. J Urol. 171(4):1419-23 2004.

Landsittel D, Singh H, Arena V, Anderson S. Null Distribution of the Likelihood Ratio Statistic for Feed Forward Neural Networks. Journal of Modern Applied Statistical Methods. 1(2):333-342. 2003.

Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Zuhowski EG, Pluim D, Joseph E, Hamburger DR, Working PK, Colbern G, Tonda ME, Potter DM, Eiseman JL. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma, 2003.

Land, S and Ganz, P. Quality of life issues with endocrine chemoprevention, to appear in Managing Breast Cancer Risk, edited by M. Morrow and V.C. Jordan, BC Decker, Inc, Hamilton, Ontario, Canada, 2003.

Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The Incidence of Lung Cancer after Surgery for Breast Cancer with and without Post-Operative Radiotherapy: Results of National Surgical Adjuvant Breast Project (NSABP) Clinical Trials B-04 and B-06. Cancer 98:1362-1368, 2003.

Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N, Wieand S. Prognostic Value of Thymidylate Synthase, Ki-67 and p53 in Patients with Dukes’ B and C colon cancer: an NCI-NSABP collaborative study. J Clin Oncol 21: 241-250, 2003.

Jeong J, Jung S, Wieand S. A Parametric Model for Long-Term Follow-up Data from Phase III Breast Cancer Clinical Trials. To appear in Statist Med 22:339-352, 2003.

Dignam JJ, Ye Y, Colangelo L, Smith R, Mamounas E, Wieand S, Wolmark N. Prognosis after Rectal Cancer in Blacks and Whites Participating in Adjuvant Therapy Randomized Trials. J Clin Oncol 21:413-420, 2003.

Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner W, Whiteside T. Overexpression of Glut-1 and Increased Glucose Metabolism in the Tumor are Associated with poor Prognosis in Oral Squamous Cell Carcinoma. Cancer 97:1015-1024, 2003.

Grumbach M, Biller B, Braunstein G, Campbell K, Carney J, Godley P, Harris E, Lee J, Oertel Y, Posner M, Schlechte J, Wieand H. Management of the Clinically Inapparent Adrenal Mass (“Incidentaloma”). Annals of Internal Medicine 138:424-429, 2003.

Smith JC, Johnson JT, Cognetti DM, Landsittel DP, Gooding WE, Cano ER, Myers EN. Quality of Life, Functional Outcome, and Costs of Early Glottic Cancer. Laryngoscope, 113 (1) 68-76, 2003.

Collins JL, Vodovotz Y, Hierholzer C, Villavicencio RT, Liu S, Alber S, Gallo D, Stolz DB, Watkins SC, Godfrey A, Gooding W, Kelly E, Peitzman AB, Billiar TR. Characterization of the Expression of Inducible Nitric Oxide Synthase in Rat and Human Liver During Hemorrhagic Shock. Shock 19(2):117-22, 2003.

Whiteside TL, Zhao Y. Tsukishiro T, Elder EM, Gooding W, Baar J. Enzyme-linked Immunospot, Cytokine Flow Cytometry, and Tetramers in the Detection of T-Cell Responses to a Dendritic Cell-based Multipeptide Vaccine in Patients with Melanoma. Clin Cancer Res 9(2):641-649, 2003.

Kuss I, Donnenberg AD, Gooding W, Whiteside TL. Effector CD8⁺ CD45RO^-CD27^-T Cells have Signaling Defects in Patients with Squamous Cell Carcinoma of the Head and Neck. Br J Cancer 88, 223-230, 2003.

Herrera LJ, Fernando HC, Perry Y, Gooding WE, Buenaventura PO, Christie NA, Luketich JD. Radiofrequency Abalation of Pulmonary Malignant Tumors in Nonsurgical Candidates. J Thorac Cardiovasc Surg (4) 929-937, 2003.

Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE, Kamens J, Grandis JR. Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck. J Biol Chem, 2003.

Whiteside TL, Gooding W. Immune Monitoring of Human Gene Therapy Trials: Potential Application to Leukemia and Lymphoma. Blood Cells Mol Dis. 31(1) 63-71, 2003.

Makhija S, Sit A, Edwards R, Aufman K, Weiss H, Kanbour-Shakir A, Gooding W, D'Angelo G, Ferrell R, Raja S, Godfrey TE. Identification of Genetic Alterations Related to Chemoresistance in Epithelial Ovarian Cancer. Gynecol Oncol. 90(1) 3-9, 2003.

Thomas SF, Coppelli FM, Wells A, Gooding WE, Song J, Kassis J, Drenning SD, Rubin-Grandis J. Epidermal Growth Factor Receptor-Stimulated Activation of Phospholipase Cγ-1 Promotes Invasion of Head and Neck Squamous Cell Carcinoma. Cancer Research 63, 5629-5635, 2003.

Tomohide T, Huang J, Gooding WE, Gambotto A, Robbins PD, Vujanovic NL, Alber SM, Watkins SC, Okada H, Storkus WJ. Intratumoral Delivery of Dendritic Cells Engineered to Secrete Both Interleukin (IL)-12 and IL-18 Effectively Treats Local and Distant Disease in Association with Broadly Reactive Tc1-type Immunity. Cancer Research 63 6378-6386 2003.

Niwa H, Wentzel AL, Li M, Gooding WE, Lui VWY, Rubin Grandis J. Antitumor Effects of Epidermal Growth Factor Receptor Antisene Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research 9 5028-5035, 2003.

Xi S, Zhang Q, Gooding WE, Smithgall TE, Rubin Grandis J. Constitutive Activation of Stat5b Contributes to Carcinogenesis in Vivo. Cancer Research 63 6763-6771, 2003.

Schlesselman JJ, Collins JA. Evaluating systematic reviews and meta-analyses. Seminars in Reproductive Medicine; 21:95-105, 2003.

Raez LE, Cassileth PA, Schlesselman JJ, Padmanabhan S, Fisher EZ, Baldie PA, Sridhar K, Podack ER. Induction of CD8 T-cell-Ifn-γ response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma. Cancer Gene Therapy; 10:850-8, 2003.

Potter D. Adaptive dose finding for phase I clinical trials of drugs used for chemotherapy of cancer. Statistics in Medicine, 21:1805-1823, 2002.

Land S, Wieand S, Day R, Ten Have T, Costantino JP, Lang W, Ganz P. Methodological Issues in the Analysis of Quality of Life Data in Clinical Trials: Illustrations from the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial, Statistical Design, Measurement, and Analysis of Health Related Quality of Life, edited by M. Mesbah, B. Cole, and M. Lee, Klewer Academic Publishers, 71-85, 2002.

Matin K, Egorin MJ, Bellesteros MF, Smith DC, Lembersky B, Day RS, Johnson CS, Trump DL. Phase I and Pharmacokinetics Study of Vinblastine and High Dose Megestrol Acetate. Cancer Chemother Pharmacol. Sep;50(3):179-85, 2002.

Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Hamburger DR, Delauter BJ, Grim A, Zuhowski EG, Joseph E, Pluim D, Potter DM, Eiseman JL. I nter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin. Clin Cancer Res 8 (9): 2992-2999, 2002.

Brissette-Storkus CS, Kettel JC, Whitham TF, Giezeman-Smits KM, Villa, LA, Potter DM, Chambers WH. Flt-3 Ligand (FL) Drives Differentiation of Rat Bone Marrow-Derived Dendritic Cells Expressing OX62 and/or CD161 (NKR-P1). J Leukoc Biol 71 (6): 941-949, 2002.

Kirkwood JM, Richards T, Zarour HM, Sosman J, Ernstoff M, Whiteside T, Ibrahim J, Blum R, Wieand S, Mascari R. Immunomodulatory Effects of High- and Low-dose IFNa2b in Patients with High-risk Resected Melanoma: The E2690 Laboratory Corollary of Intergroup Adjuvant Trial E1690. Cancer 95:1101-1112, 2002.

Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RVP, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol:20 3628-3636, 2002.

Lango MN, Dyer KF, Lue VW, Gooding WE, Gubish C, Siegfried JM, Grandis JR. Gastrin-releasing Peptide Receptor-Mediated Autocrine Growth in Squamous Cell Carcinoma of the Head and Neck. J Natl Cancer Inst. 94(5):375-83, 2002.

Raja S, Luketich JD, Kelly LA, Gooding WE, Finkelstein SD, Godfrey TE. Rapid, Quantitative Reverse Transcriptase-Polymerase Chain Reaction: Application to Intraoperative Molecular Detection of Occult Metastases in Esophageal Cancer. J Thorac Cardiovasc Surg, 123(3):475-83, 2002.

Bennouna J, Hildesheim A, Chikamatsu K, Gooding W, Storkus WJ, Whiteside TL. Application of IL-5 ELISPOT Assays to Quantification of Antigen-Specific T helper Responses. J Immuno Meth 261, 145-156, 2002.

Meidenbauer N, Gooding W, Spitler L, Harris D, Whiteside TL. Recovery of ζ Chain Expression and Changes in Spontaneous IL-10 Production after PSA-based Vaccines in Patients with Prostate Cancer. British Journal of Cancer, 86, 168-178, 2002.

Hoffman TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL. Spontaneous Apoptosis of Circulating t Lymphocytes in Patients with Head and Neck Cancer and its Clinical Importance. Clinical Cancer Research, 8:2553-2562, 2002

Kijima, T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Si S, Rubin-Grandis J. STAT3 Activation Abrogates Growth Factor Dependence and Contributes to Head and Neck Squamous Cell Carcinoma Tumor Growth in Vivo. Cell Growth & Differentiation 13: 355-362, 2002.

Reichert T, Strauss L, Wagner EM, Gooding W, Whiteside TL. Signaling Abnormalities, Apoptosis, and Reduced Proliferation of Circulating and Tumor-infiltrating Lymphocytes in Patients with Oral Carconoma. Clin. Cancer Res. 8: 3137-3145, October 2002.

Zeng Q, Kanter PM, Dhir R, Gooding WE, Huang L, Rubin-Grandis J. Lack of Toxicity of EGFR Antisense Gene Therapy. J Exp Therap Oncol. 2:174-186, 2002.

Logan FL, Jadali F, Egorin MJ, Mintum M, Sashin D, Gooding WE, Cho Y, Bishop H, Trump DL, Gardner D, Kirkwood J, Vlock D, Johnson C. Decreased Tumor Blood Flow as Measured by Positron Emission Tomography in Cancer patients treated with interleukin-1 and carboplatin on a phase I trial. Cancer Chemother Pharmacol 50: 433-444, 2002.

Kuss I, Rabinowich H, Gooding W, Edwards R, Whiteside TL. Expression of ζ in T cells prior to Interleukin-2 Therapy as a Predictor of response and survival in patients with Ovarian Carcinoma. Cancer Biother Radiopharm 17(6):631-40, 2002.

Hmelo CE, Nagarajan A, and Day RS. "It's Harder than we Thought it would be": A Comparative Case Study of Expert-novice Experimentation Strategies. Science Education, 86 219-243, 2002.

Zarour HM, Maillere B, Brusic V, Coval K, Williams E, Pouvelle-Moratille S, Castelli F, Land S, Bennouna J, Logan T, Kirkwood JM. NY-ESO-1 119-143 is a Promiscuous MHC Class II T-helper Epitope Recognized by Th1 and Th2- type Tumor-Reactive CD4+ T cells. Cancer Res, 62: 213-218, 2002.

Rose C, Green M, Webber S, Kingsley L, Day R, Watkins S, Reyes J, Rowe D. Detection of EBV Genomes in Peripheral Blood B Cells From Solid Organ Transplant Recipients by Fluorescent in situ Hybridization. J Clin Microbiol. 40(7):2533-44, 2002.

Fisher B, Land L, Mamounas E, Dignam J, Fisher ER, Wolmark N. The Prevention of Invasive Breast Cancer in Women with a History of Ductal Carcinoma in situ (DCIS): An update of the NSABP Experience, Ductal Carcinoma in Situ, 2^nd edition, edited by M.J. Silverstein, Lippincott Williams & Wilkins, Philadelphia, 2002.

Muindi JR, Yibing P, Potter DM, Tauch JS, Capozzoli MJ, Egorin MJ, Johnson CS, Trump DL. Pharmacokinetics of high dose, oral calcitriol: results obtained during a phase one trial of calcitriol and paclitaxel. Clin Pharm and Therapeutics, 72:648-659, 2002.

Collins JA, Schlesselman JJ. Perimenopausal use of reproductive hormones: effects on breast and endometrial cancer. Obstet Gynecol Clin North Am; 29:511-25, 2002.

Walker GR, Schlesselman JJ, Ness RB. Family history of cancer, oral contraceptive use, and ovarian cancer risk. Am J Obstet Gynecol; 186:8-14, 2002.

Sofer M, Hamilton-Nelson KL, Schlesselman JJ, Soloway MS. Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. J Clin Oncol; 20:1853-58, 2002.

Ramanathan RK, Potter D, Jacobs SA, Belani CP, Lim F, Kim H, Savona S, Evans T, Buchbarker D, Simon MB, Depee J, Wilson S, Gravenstein S, Trump DL. A randomized trial of influenze vaccine with GM-CSF or placebo in cancer patients. JCO, 21:4313-4318, 2002.

Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer, 91(11):2136-2147, 2001.

Land, S. and Wieand, H.S. Invited discussion of "Bayesian Designs for Dose-Ranging Drug Trials" by Berry, D.A., Mueller, P., Grieve, A.P., Smith, M., Parke, T., Blazek, R., Mitchard, N., Brearley, C. and Krams, M. Case Studies in Bayesian Statistics, Carnegie Mellon University, 2001.

King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Costantino J, Wickerham L, Wolmark N, Fisher B. Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2 from the NSABP P-1 Breast Cancer Prevention Trial, Journal of the American Medical Association, 2001.

Hmelo CE, Ramakrishnan, Day RS, Shirey WE, Brufsky A, Johnson C, Baar J, Huang Q. The Oncology Thinking Cap: Scaffolded Use of a Simulation to Learn Clinical Trial Design. Teaching and Learning in Medicine, 13(3), 2001.

Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL. Decreased -Chain Expression and Apoptosis in CD3+ Peripheral Blood T lymphocytes of Patients with Melanoma. Clinical Cancer Research, 7 947-957, March 2001.

Kijima T, Kinukawa N, Gooding WE, Uno M. Association of Epstein-Barr virus with Tumor Cell Proliferation: Clinical Implication in Nasopharyngeal Carcinoma. I nternational Journal of Oncology, 18: 479-485, 2001.

Lew JI, Gooding WE, Ribeiro, Jr U, Safatle-Ribeiro AV, Posner MC. Long-term Survival Following Induction Chemo Radiotherapy and Esophagectomy for Esophageal Carcinoma. Archives of Surgery, 136 737-742, July 2001.

Posner MC, Gooding WE, Lew JI, Rosenstein MM, Lembersky BC. Complete 5-year Follow-up of a Prospective Phase II Trial of Preoperative Chemoradiotherapy for Esophageal Cancer. Surgery, 130 (4) 620-628, Oct. 2001.

Raja S, Finkelstein SD, Baksh FK, Gooding WE, Swalsky PA, Godfrey TE, Buenaventura PO, Luketich J. Correlation between Dysplasia and Mutations of Six Tumor Suppressor Genes in Barrett's Esophagus. Ann. Thorac. Surg. , 72 (4) 1130-1135, Oct 2001.

Simons JP, Johnson JT, Yu VL, Vickers RM, Gooding WE, Myers EN, Pou AM, Wagner RL, Grandis JR. The Role of Topical Antibiotic Prophylaxis in Patients Undergoing Contaminated Head and Neck Surgery with Flap Reconstruction. Laryngoscope 1(2): 329-335, February 11, 2001.

Godfrey E, Raja S, Finkelstein D, Gooding WE, Kelly LA, Luketich D. Prognostic Value of Quantitative Reverse Transcription-Polymerase Chain Reaction in Lymph Node-Negative Esophageal Cancer Patients. Clin Cancer Res. 7 4041-4048, 2001.

Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of Invasive Breast Cancer in Women with Ductal Carcinoma in situ: An Update of the National Surgical Adjuvant Breast and Bowel Project experience, Semin Oncol. Aug;28(4):400-18, 2001.

Wahlberg BJ, Burholdt DR, Kornblith P, Richards TJ, Brufsky A, Herberman RB, Vujanovic NL. Measurement of NK Activity by the Microcytotoxicity Assay (MCA): A New Application for an Old Assay. Journal of Immunological Methods, 253, 69-81, 2001.

Zamboni WC, D’Argenio DZ, Stewart CF, MacVittie T, Delauter BJ, Farese AM, Potter DM. Kubat NM, Tubergen D, Egorin MJ. Pharmacodynamic Model of Topotecan-Induced Time Course of Neutropenia. Clinical Cancer Research 7 (8): 2301-08, 2001.

Okada H, Pollack IF, Lieerman F, Lunsford LD, Kondziolka D, Schiff D, Attanucci J, Edington H, Chambers W, Kalinski P, Kinzler D, Whiteside T, Elder E, Potter D. Gene Therapy of Malignant Gliomas: A Pilot Study of Vaccination with Irradiated Autologous Glioma and Dendritic Cells Admixed with IL-4 Transduced Fibroblasts to Elicit an Immune Response. Hum Gene Ther. 12(5):575-95, 2001.

Kirkwood JM, Mascari RA, Edington HD, Rabkin MS, Day RS, Whiteside TL, Vlock DR, Shipe-Spotloe JM. Analysis of therapeutic and immunologic effects of R-24 anti-GD# monoclonal antibody in 37 patients with metastatic melanoma. Cancer, 88(12): 2693-2702, June 15, 2000.

Ness RB, Grisso JA, Klapper J, Schlesselman JJ, Silberzweig S, Vergona R, Morgan M, Wheeler JE, and the SHARE Study Group. Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. Am J Epidemiol;152:233-241, 2000.

Mies C, Schlesselman JJ. Detection of "occult" lymph node metastasis in breast cancer: Should pathologists go the extra mile? Adv Anatomic Pathol; 7:149-152, 2000.

Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, Morgan M, Schlesselman JJ. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology; 11:111-117, 2000.

Hmelo CE, Nagarajan A, and Day RS. Effects of High and Low Prior Knowledge on Construction of a Joint Problem Space. J ournal of Experimental Education, 69, 36-56, 2000.

Kirkwood JM, Mascari RA, Edington HD; Rabkin MS, Day RS, Whiteside TL, Vlock DR, Shipe-Spotloe JM. Analysis of Therapeutic and Immunologic Effects of R-24 Anti-GD# Monoclonal Antibody in 37 Patients with Metastatic Melanoma. Cancer, 88(12): 2693-2702, June 15, 2000.

Konety BR, Nguyen TST, Dhir R, Day RS, Becich MJ, Stadler WM, Getzenberg RH. Detection of Bladder Cancer Using a Novel Matrix Protein, BLCA-4. Clinical Cancer Research. 6, 2618-2625, July 2000.

Zamboni WC, Egorin MJ, Van Echo DA, Day RS, Meisenberg BR, Brooks SE, Doyle LA, Nemieboka NN, Dobson JM, Tait NS, Tkaczuk KH. Pharmacokinetic and Pharmacodynamic Study of the Combination of Docetaxel and Topotecan in Patients with Solid Tumors. Journal of Clinical Oncology, 18(18): 3288-3294, 2000.

Gerszten K, Faul C, King G, Nagappan S, Sonnik D, Gooding W. The Feasibility of Using a Single Dosimetry Plan for Fractionated High Dose Rate Brachytherapy with a Ring and Tandem Applicator. Journal of Brachytherapy International, 16: 123-130, 2000.

Grandis JR, Faulkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA. Human Leukocyte Antigen Class I Allelic and Haplotype Loss in Squamous Cell Carcinoma of the Head and Neck: Clinical and Immunogenetic Consequences. Clinical Cancer Research, 7:2794-2802, 2000.

King GC, Bloomer WD, Kalnicki S, Faul CM, Gooding WE, Stockstill, TF, Wu A, Buchsbaum R, Chen S, Gerszten K, Kalend A. Point Dose Variations with Time During Traditional Brachytherapy for Cervical Carcinoma. Med. Dosim, 25(2): 77-80, 2000.

Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL. Spontaneous Apoptosis of CD8+ T Lymphocytes in Peripheral Blood of Patients with Advanced Melanoma. Clinical Cancer Research, 6:1351-1364, 2000.

Zeng Q, Smith DC, Suscovich TJ, Gooding WE, Trump DL, Grandis JR. Determination of Intermediate Biomarker Expression Levels by Quantitative Reverse Transcription-Polymerase Chain Reaction in Oral Mucosa of Cancer Patients Treated with Liarozole. Clinical Cancer Research, 6:2245-2251, 2000.

Faul C, Gerszten K, Edwards R, Land S, D'Angelo G, Kelley III, J, Price F. A Phase I/II Study of Hypofractionated Whole Abdominal Radiation Therapy in Patients with Chemoresistant Ovarian Carcinoma: Impact on Quality of Life. International Journal of Radiation Oncology, Biology, and Physics. 47 (3): 749-54, Jun 1 2000.

Emir B, Wieand S, Jung S, Ying Z. Comparison of Diagnostic Markers with Repeated Measurements: A Non-Parametric Aapproach. Statist in Med 19: 511-523, 2000.

Wolmark N, Wieand HS, Hyams DM, Colangelo L, et al. Randomized Trial of Postoperative Adjuvant Chemotherapy with or without Radiotherapy for Carcinoma of the Rectum: NSABP Protocol R-02. J Natl Cancer Inst 92:388-396, 2000.

Belani CP, Aisner J, Ramanathan R, Jett J, Greenberger J, Day R, Capazolli MJ, Hiponia D, Engstrom C. Paclitaxel and Carboplatin with Simultaneous Thoracic Irradiation in Regionally Advanced Non-Small Cell Lung Cancer. Seminars in Radiation Oncology, 7(2): S1-S11-S13-S-14, 1999.

Day RS, Huang QS, Ramakrishnan S. Pseudorandom Number Generators, Goodness of Fit Tests, and Stochastic Simulation of Heterogeneous Tumors. Proceedings of the Joint Statistical Meetings, August 1999.

Dignam JJ, Day RS, Bryant J. Statistical Exploration into Long-Term Tamoxifen Efficacy in the Treatment of Early Breast Cancer. Proceedings of the ENAR Joint Statistical Meetings, August 1999.

Hmelo C. and Day R. Contextualized Questioning to Scaffold Learning from Simulation. Computers and Education, 32:151-164, 1999.

Joe BN, Fukui MB, Meltzer CC, Huang Q, Day RS, Greer PJ, Bozik ME. Brain Tumor Volume Measurement: Comparison of Manual and Semiautomated Methods. Radiology. Sept.1999. 212(3): 811-816, 1999.

Nagarajan A, Hmelo CE, Day RS. Collaborative Scientific Inquiry in a Simulated Laboratory. Proceedings of Computer Supported Collaborative Learning, 1-12, 1999.

Agarwala SS, Ferri W, Gooding W, Kirkwood JM. A Phase III Randomized Trial of Dacarbazine and Carboplatin With and Without Tamoxifen in the Treatment of Patients with Metastatic Melanoma". Cancer 85(9): 1979-1984, 1999.

Posner MC, Gooding WE, Landreneau RJ, Rosenstein MM, Clark MR, Peterson MS, Lembersky BC. Preoperative Chemo Radiotherapy for Carcinoma of the Esophagus and Gastroesophageal Junction. The Cancer Journal from Scientific American, 4:237-246, 1999.

Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL. Spontaneous ex Vivo Apoptosis of Peripheral Blood Mononuclear Cells in Patients with Head and Neck Cancer. Clinical Cancer Research, 5:1263-1273, 1999.

Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS. Validation Studies for Models to Project the Risk of Invasive and Total Breast Cancer Incidence. J Natl Cancer Inst 91:1541-1548, 1999.

Jung S, Wieand S. Analysis of Goodness-of-Fit Test for Cox Regression Model. Statistics and Probability Letters 41: 379-382, 1999.

Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham L, Bear HD, Atkins JN, Dimitrov NV, Glass AG, Fisher E, Fisher B. A clinical Trial to Assess the Relative Efficacy of 5-FU + Leucovorin, 5-FU + Levamisole, and 5-FU + Leucovorin + Levamisole in Patients with Dukes' B and C Carcinoma of the Colon: Results from NSABP C-04. J Clin Oncol 17: 3553-3559, 1999.

Collins JA, Schlesselman JJ. Hormone replacement therapy and endometrial cancer. In Lobo Red. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, 2nd edition. New York: Lippincott-Raven, 503-511, 1999.

Schlesselman JJ, Collins JA. The influence of steroids on gynecologic cancers. In Fraser IS, Jansen RPS, Lobo RA, Whitehead MI, eds. Estrogens and Progestogens in Clinical Practice. London: Churchill Livingstone, 831-864, 1998.

Adedoyin A, Stiff DD, Smith DC, Romkes M, Bahnson RC, Day R, Hofacker J, Branch RA, Trump DL. All-trans-retinoic Acid Modulation of Drug-Metabolizing Enzyme Activities: Investigation with Selective Metabolic Drug Probes. Cancer Chemotherapy Pharmacology, 41:133-139, 1998.

Hmelo CE, Ramakrishnan S, Day RS, Shirey WE, Huang Q. Scaffolded Use of a Modeling Tool to Support Scientific Inquiry. Proceedings of the International Conference on Computers and Education: Global Education on the Net, Beijing China: ICCE, pp. 381-387, 1998.

Hmelo CE, Ramakrishnan S, Day RS, Shirey WE, Huang Q, Baar J. Developing Inquiry Skills Through Scaffolded Use of a Simulation. In A. Bruckman, M. Guzdial, J. L. Kolodner, A. Ram (Eds)., Proceedings of the Third International Conference on the Learning Sciences, Charlottesville, VA: AACE., pp. 145-151, 1998.

Pitman KT, Johnson JT, Edington H, Barnes EL, Day R, Wagner RL, Myers EN. Lymphatic Mapping with Isoulfan Blue Dye in Head and Neck Squamous Cell Carcinoma. Archives of Otolaryngology and Head and Neck Surgery, 124(7): 790-793, 1998.

Ramakrishnan S, Hmelo CE, Day RS, Huang Q. The Integration of a Novice User Interface into a Professional Modeling Tool. Proceedings of the AIMA Annual Symposium, 678-82, 1998.

Reichert TE, Day RS, Wagner EM, Whiteside TL. Absent or Low Expression of the Chain in T Cells at the Tumor Site Correlates with Poor Survival in Patients with Oral Carcinoma. Cancer Research, 58(23): 5344-5347, 1998.

Grandis JR, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ. Tumor Levels of TGF-á and EGFR Protein Predict Survival in Patients with Head and Neck Squamous Cell Carcinoma. Journal of the National Cancer Institute, 90:824-832, 1998.

Ribeiro U, Finkelstein SD, Safatle Ribeiro AV, Landreneau RJ, Clarke MR, Bakker A, Swalsky PA, Gooding WE, Posner MC. "P53 Sequence Analysis Predicts Treatment Response and Outcome of Patients with Esophageal Carcinoma." Cancer 83(1): 7-18, 1998.

Dignam J, Bryant J, Wieand S, Fisher B, Wolmark N. Early Stopping of a Clinical Trial When There is Evidence of no Treatment Benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project. Controlled Clinical Trials 19:575-588, 1998.

Emir B, Wieand S, Su J, Cha S. Analysis of Repeated Markers Used to Predict Progression of Cancer. Statist in Med 17: 2563-2578, 1998.

Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N, and other National Surgical Adjuvant Breast and Bowel Project Investigators. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1385, 1998.

Mamounas E, Wieand S, Wolmark N, Bear H, Atkins J, Song K, Jones J, Rockette H. Comparative Efficacy of Adjuvant Chemotherapy in Patients with Dukes' B versus Dukes' C Colon Cancer: Results from four NSABP Adjuvant Studies (C-01, C-02, C-03, C-04). J Clin Oncol 17:295-300, 1998.

O'Connell M, Laurie J, Kahn M, Fitzgibbons R, Erlichman C, Shepherd L, Kocha W, Pazdur R, Wieand HS, Rubin J, Vukov A, Donohue J, Krook J, Figueredo A. A Prospectively Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients with High-Risk Colon Cancer. J Clin Oncol 16:295-300, 1998.